Open Accessibility Menu
Hide

Theodore Catranis, MD

  • Infirmary Medical Clinics
  • Infirmary Physician Alliance
  • NPI Number: 1942201223
  • Primary Specialty: Obstetrics
  • Additional Specialty: Gynecology
  • Languages Spoken: English
  • Gender: Male

About Theodore

Dr. Thedore "Ted" Catranis is an OB-GYN with Women's Health Alliance of Mobile. He is board certified by the American Board of Obstetrics and a Gynecology Fellow American College of Obstetrics and Gynecology. Dr. Catranis delivers at Mobile Infirmary and North Baldwin Infirmary. He is an extremely active member of the local and regional medical community. Activities include:

  • Medical Association of the State of Alabama
  • Medical Society of Mobile County
  • Mobile County Board of Censors 2004-2006
  • Mobile County Board of Health 2004-2006
    • Chairman, 2006
    • Secretary, 2004
  • Mobile Bay OB-GYN Society
  • Advisory Board, Penelope House Family Violence Center
  • Alabama Baby Coalition Case Review Chair 2006-2007
  • Alabama Baby Coalition Chairman 2007-Current
  • Region IV Perinatal Advisory Committee 2017-Current
Affiliations Mobile Infirmary, North Baldwin Infirmary, Women's Health Alliance of Mobile
Education
  • Medical School
  • University of Alabama at Birmingham

    Birmingham, AL
    1990

  • Internship
  • Tulane University

    New Orleans, LA
    1991

  • Residency
  • Tulane University

    New Orleans, LA
    1994

Medical Interests Research Interests:

Dr. Catranis is the principal investigator in the following areas of research:

1. Bayer Asteroid 6: Assess Safety and Efficacy of Vilaprisan Subjects with Uterine Fibroids

2. Abbvie M14-702: A Clinical Study to Evaluate the Safety and Efficacy of Elagolix In Participants with Moderate to Severe Endometriosis-Associated Pain

3. Abbvie M16-283: Long-Term Safety and Efficacy of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

4. Abbvie M18-969:Elaris EM-COC Study for Endometriosis Pain, A Phase 3b Study to Evaluate the Safety and Efficacy of Elogolix in combination with combined Oral contraceptives in premenopausal Women with documented Endometriosis and Associated Moderate-to-Severe Pain.